Quantcast

Latest Anticonvulsants Stories

2011-04-12 08:07:52

(Ivanhoe Newswire) -- The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain -- the burning or tingling pain in the hands and feet that affects millions of people with diabetes. Diabetic nerve pain, or neuropathy, is caused by nerve damage. "When neuropathy strikes, it is painful and can disrupt sleep; because of this, it can also lead to mood changes and lower quality of life," lead guideline author Vera Bril, MD, FRCP, with the...

2011-04-12 00:00:30

Topamax birth defect claims are being investigated across the country as parents may be unknowingly exposing infants to the anticonvulsant drug in utero, possibly increasing the risk of major birth defects. Topamax is an anticonvulsant medication manufactured by Johnson & Johnson and approved by the FDA in 1996 to treat individuals suffering from epilepsy and migraine headaches. The Consumer Justice Foundation has developed http://www.topamaxbirthinjury.com to help parents that have...

2011-04-12 00:00:30

As more victims of Depakote use during pregnancy speak out about the birth defects that have affected the lives of their families, Depakote attorneys working with the Consumer Justice Foundation website http://www.depakotebirthinjury.com are trying to recoup compensation for the life long medical care that will be required to treat children born with skeletal defects. The Consumer Justice Foundation is a resource for the American people who have been adversely affected by corporate entities...

2011-04-11 08:00:00

MAPLE GROVE, Minn., April 11, 2011 /PRNewswire/ -- Upsher-Smith Laboratories today announced the presentation of data indicating that once daily administration of USL255, a proprietary extended-release (ER) formulation of the epilepsy medication topiramate, was associated with less fluctuation in topiramate plasma levels compared to immediate-release (IR) topiramate administered twice daily in healthy volunteers. These data were presented Monday, April 11 at the American Academy of...

2011-04-07 07:02:00

SILVER SPRING, Md., April 7, 2011 /PRNewswire-USNewswire/ -- On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) RLS is a disorder that causes a strong urge to move the legs. This urge often occurs with unpleasant feelings in the legs. People who have RLS describe feeling pulling, itching,...

2011-03-30 00:00:28

The Senators Firm announced today that it is offering free confidential case reviews to people who took Topamax during pregnancy and suffered Topamax induced cleft lip, cleft palate, and oral cleft birth defects. Victims of Topamax birth defects may be eligible to file a Topamax lawsuit. Newport Beach, CA (PRWEB) March 28, 2011 The Senators (Ret.) Firm, LLP, announced today that it is continuing to investigate a number of reported cases of birth defects in children born to mothers who...

2011-03-29 11:15:00

LONDON and MISSISSAUGA, Ontario, March 29, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that the European Commission has granted marketing authorisation for Trobalt(TM) (retigabine) as an adjunctive (add-on) treatment of partial onset seizures (a form of epilepsy where a seizure begins in a specific area in one side of the brain), with or without secondary generalisation in adults aged 18 years and above...

2011-03-28 17:26:56

Study in mice highlights alternative anti-inflammatory approach to epilepsy management If common anticonvulsant drugs fail to manage epileptic seizures, then perhaps the anti-inflammatory* route is the way to go. That's according to Mattia Maroso and colleagues from the Mario Negri Institute for Pharmacological Research in Milan, Italy, who found that giving mice repeated doses of a specific enzyme inhibitor significantly reduced both chronic epileptic activity and acute seizures. Their...

2011-03-28 00:00:27

As lawsuits against the makers of the epilepsy drug Depakote begin to surface in the United States, Depakote lawyers begin to consult with families of birth defect victims about possible Depakote lawsuits. Depakote is a prescription anticonvulsant used to treat epilepsy and the manic phase of bipolar disorder. Depakote Birth Injury Resources provides online information about possible Depakote birth defects and means to connect with Depakote lawyers. (PRWEB) March 26, 2011 As new studies...

2011-03-24 14:19:28

The drug, called carbamazepine, is commonly used to treat patients with epilepsy and other diseases such as depression and trigeminal neuralgia. Although successful in treating the majority of patients, carbamazepine can cause side-effects that range from a mild skin irritation to severe blistering of the whole body. The team, in collaboration with the Wellcome Trust Sanger Institute, screened more than a million variants in DNA across the human genome to understand why some patients are more...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related